Cargando…
Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874977/ https://www.ncbi.nlm.nih.gov/pubmed/33589286 http://dx.doi.org/10.1016/j.arcmed.2021.02.004 |
| _version_ | 1783649697744814080 |
|---|---|
| author | Sookaromdee, Pathum Wiwanitkit, Viroj |
| author_facet | Sookaromdee, Pathum Wiwanitkit, Viroj |
| author_sort | Sookaromdee, Pathum |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7874977 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78749772021-02-11 Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19 Sookaromdee, Pathum Wiwanitkit, Viroj Arch Med Res Letter to the Editor Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2021-07 2021-02-10 /pmc/articles/PMC7874977/ /pubmed/33589286 http://dx.doi.org/10.1016/j.arcmed.2021.02.004 Text en © 2021 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Sookaromdee, Pathum Wiwanitkit, Viroj Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19 |
| title | Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19 |
| title_full | Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19 |
| title_fullStr | Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19 |
| title_full_unstemmed | Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19 |
| title_short | Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID‐19 |
| title_sort | bioinformatics analysis for screening of therapeutic drugs in covid‐19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874977/ https://www.ncbi.nlm.nih.gov/pubmed/33589286 http://dx.doi.org/10.1016/j.arcmed.2021.02.004 |
| work_keys_str_mv | AT sookaromdeepathum bioinformaticsanalysisforscreeningoftherapeuticdrugsincovid19 AT wiwanitkitviroj bioinformaticsanalysisforscreeningoftherapeuticdrugsincovid19 |